BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 69 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,551,528 | -12.0% | 246,463 | +0.2% | 0.01% | -16.7% |
Q2 2023 | $4,037,825 | -5.5% | 245,909 | -3.9% | 0.01% | 0.0% |
Q1 2023 | $4,273,947 | +9.3% | 255,771 | +0.9% | 0.01% | 0.0% |
Q4 2022 | $3,910,136 | -8.6% | 253,407 | -11.6% | 0.01% | -14.3% |
Q3 2022 | $4,279,000 | -6.3% | 286,598 | +3.1% | 0.01% | 0.0% |
Q2 2022 | $4,569,000 | -15.1% | 278,100 | +3.6% | 0.01% | 0.0% |
Q1 2022 | $5,383,000 | -18.0% | 268,341 | +3.7% | 0.01% | -22.2% |
Q4 2021 | $6,563,000 | +11.4% | 258,807 | +18.5% | 0.01% | 0.0% |
Q3 2021 | $5,893,000 | +3.1% | 218,420 | +10.5% | 0.01% | 0.0% |
Q2 2021 | $5,715,000 | +20.9% | 197,614 | +10.0% | 0.01% | +12.5% |
Q1 2021 | $4,727,000 | +30.1% | 179,722 | +41.7% | 0.01% | +33.3% |
Q4 2020 | $3,634,000 | +7.7% | 126,838 | -10.3% | 0.01% | -14.3% |
Q3 2020 | $3,373,000 | +23.6% | 141,447 | +8.4% | 0.01% | +16.7% |
Q2 2020 | $2,730,000 | +206.7% | 130,546 | +164.7% | 0.01% | +200.0% |
Q1 2020 | $890,000 | – | 49,316 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EPIQ PARTNERS, LLC | 169,250 | $4,451,000 | 2.55% |
Cornerstone Advisors, LLC | 459,157 | $12,076,000 | 1.06% |
Matisse Capital | 250,000 | $6,574,000 | 0.95% |
TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 45,356 | $1,193,000 | 0.94% |
1607 Capital Partners, LLC | 423,925 | $11,149,000 | 0.54% |
Thomas J. Herzfeld Advisors, Inc. | 33,722 | $887,000 | 0.40% |
KAVAR CAPITAL PARTNERS GROUP, LLC | 39,750 | $1,045,000 | 0.28% |
Stockman Wealth Management, Inc. | 20,296 | $534,000 | 0.15% |
Karpus Management, Inc. | 186,631 | $4,908,000 | 0.15% |
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD | 100,211 | $2,631,000 | 0.14% |